Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in South Korea / NCT04320199
Recruiting Not applicable

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

NCT04320199 · tracked via the Priya Life Science South Korea tracker
Sponsor
Pusan National University Yangsan Hospital
Phase
Not applicable
Started
2020-01-01
Last updated
2025-06-04

Condition(s) studied

Alcoholic Liver Disease

Investigational drug(s) / intervention(s)

Fermented Protaetia brevitarsis seulensis powder groupPlacebo group

Fermented Protaetia brevitarsis seulensis powder group: This group takes Fermented Protaetia brevitarsis seulensis powder for 8 weeks

Placebo group: This group takes placebo for 8 weeks

Study summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Gamma-glutamyl transferase ranging from upper limit of reference to four times of upper limit Exclusion Criteria: * Abnormal liver or renal function (i.e., serum aminotransferase activity \> 3 times of upper limit of reference range and serum creatinine concentrations \> 1.2 mg/dL) * Diabetes (diagnosed clinically or fasting glucose level \> 126 mg/dL) * History of viral hepatitis or cancer * Uncontrolled hypertension * History of serious cardiac disease such as angina or myocardial infarction * History of gastrectomy * History of medication for psychiatric disease * Administration of oriental medicine including herbs within the past 4 weeks

Primary outcome measure(s)

  • Concentration of Gamma-Glutamyl Transpeptidase — 8 weeks
    Gamma-Glutamyl Transpeptidase

Trial sites (1)

FacilityCityRegionStatus
Pusan National University Yangsan Hospital Pusan Ami-dong Recruiting

More Pusan National University Yangsan Hospital trials in South Korea

HB05P on Muscle Health Recruiting
Cardiovascular Autonomic Function After Resistance Training Starting soon
Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block Active, not recruiting
The Study to Evaluate the Safety and Efficacy of the Onyx Family Recruiting
Electromagnetic High-Frequency Chest Wall Oscillation on Pulmonary Mucus Clearance in Patients With Impaired Self-Expectoration Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04320199 on ClinicalTrials.gov ↗ ← All trials in South Korea